Cytek Biosciences (CTKB) Earnings Date, Estimates & Call Transcripts → Trump’s Gift Could Unleash $51 Billion in New Wealth (From Wealthpin Pro) (Ad) Free CTKB Stock Alerts $5.63 -0.05 (-0.88%) (As of 05/31/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateAug. 13EstimatedActual EPS (May. 8) -$0.05 Consensus EPS (May. 8) -$0.05 Get Cytek Biosciences Earnings AlertsEnter your email address below to receive the latest news and earnings results for CTKB and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueCTKB Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CTKB Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Porter & CompanyThis military-backed stock “owns” AI marketThe AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. Cytek Biosciences Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($0.05) EPSNext Year EPS Consensus Estimate: $0.05 EPSCTKB Earnings Date and InformationCytek Biosciences last announced its earnings results on May 8th, 2024. The reported ($0.05) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.05). The business earned $44.86 million during the quarter, compared to analyst estimates of $43.86 million. Cytek Biosciences has generated ($0.09) earnings per share over the last year (($0.09) diluted earnings per share). Earnings for Cytek Biosciences are expected to grow in the coming year, from ($0.05) to $0.05 per share. Cytek Biosciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off prior year's report dates.Read More Cytek Biosciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/13/2024(Estimated)------- 5/8/2024Q1 2024($0.05)($0.05)-($0.05)$43.86 million$44.86 million3/13/2024Q4 2023-$0.04+$0.04$0.04$56.66 million$58.23 million11/7/2023Q3 2023($0.01)($0.03)($0.02)($0.01)$55.09 million$48.00 million8/8/2023Q2 2023-($0.02)($0.02)($0.01)$46.52 million$49.69 million5/9/2023Q1 2023-($0.03)($0.03)($0.01)$46.21 million$37.09 million2/28/2023Q4 2022$0.02$0.03+$0.01$0.03$49.87 million$48.34 million Get the Latest News and Ratings for CTKB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cytek Biosciences and its competitors with MarketBeat's FREE daily newsletter. 11/9/2022Q3 2022$0.02$0.01($0.01)$0.01$43.36 million$40.48 million8/10/2022Q2$0.02$0.03+$0.01-$41.34 million$40.16 million 5/11/2022Q1 2022$0.01($0.02)($0.03)($0.02)$33.00 million$35.06 million 2/23/2022Q4 2021-$0.05+$0.05$0.10-$38.89 million11/8/2021Q3 2021$0.02$0.02---$34.38 million Cytek Biosciences Earnings - Frequently Asked Questions When is Cytek Biosciences's earnings date? Cytek Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off last year's report dates. Learn more on CTKB's earnings history. Did Cytek Biosciences beat their earnings estimates last quarter? In the previous quarter, Cytek Biosciences (NASDAQ:CTKB) reported ($0.05) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.05). Learn more on analysts' earnings estimate vs. CTKB's actual earnings. How much revenue does Cytek Biosciences generate each year? Cytek Biosciences (NASDAQ:CTKB) has a recorded annual revenue of $193.01 million. How much profit does Cytek Biosciences generate each year? Cytek Biosciences (NASDAQ:CTKB) has a recorded net income of -$12.15 million. CTKB has generated -$0.09 earnings per share over the last four quarters. What is Cytek Biosciences's EPS forecast for next year? Cytek Biosciences's earnings are expected to grow from ($0.05) per share to $0.05 per share in the next year. More Earnings Resources from MarketBeat Related Companies: Valneva Earnings Date Prothena Earnings Date Allogene Therapeutics Earnings Date Myriad Genetics Earnings Date Olink Holding AB (publ) Earnings Date 10x Genomics Earnings Date Standard BioTools Earnings Date Quanterix Earnings Date EyePoint Pharmaceuticals Earnings Date Pacific Biosciences of California Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Hormel: A Potential Buy Despite Post-Earnings DeclineCanopy Growth’s Earnings: Profitability Despite Industry ShiftsAbercrombie & Fitch First Quarter Earnings Surge to New HeightsTD Bank Q2 Earnings: Record Highs and Regulatory HurdlesPDD Holdings Earnings Volatility Alerts Buyers Zoom Stock’s Earnings Volatility Picked Up a Lot of BuyersBaidu Stock Earnings Prove Ray Dalio Right about China? This page (NASDAQ:CTKB) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressBiden Nomination CANCELED?The Freeport SocietyNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cytek Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.